(Q36548672)

English

Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England

scientific article published on January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

author name string

Deborah Layton

1

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Vanessa Marshall

2

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Andrew Boshier

3

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Peter Friedmann

4

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Saad A W Shakir

5

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

687-696

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Harmonizing the use of adverse-drug reaction terms. Definitions of terms and minimum requirements for their use: respiratory disorders and skin disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/16872242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the extent of under-reporting of serious adverse drug reactions: the case of toxic epidermal necrolysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16872242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16872242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16872242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/16872242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/16872242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16872242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A case of rofecoxib-associated stevens-johnson syndrome with corneal and conjunctival changes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16872242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stevens-Johnson syndrome and antiepileptics

1 reference

https://pubmed.ncbi.nlm.nih.gov/16872242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An international comparison of case definition of severe adverse cutaneous reactions to medicines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16872242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential diagnosis of severe cutaneous drug eruptions

1 reference

https://pubmed.ncbi.nlm.nih.gov/16872242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxic epidermal necrolysis: current evidence, practical management and future directions

1 reference

https://pubmed.ncbi.nlm.nih.gov/16872242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Valdecoxib-induced toxic epidermal necrolysis in a patient allergic to sulfa drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/16872242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00002018-200629080-00005

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36548672&oldid=2199021318"